Avoid common mistakes on your manuscript.
Correction to: Investigational New Drugs (2018) 36:743–754
The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s10637-017-0558-5
Rights and permissions
About this article
Cite this article
Zhao, P., Aguilar, A.E., Lee, J.Y. et al. Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway. Invest New Drugs 37, 1309 (2019). https://doi.org/10.1007/s10637-019-00772-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-019-00772-w